Introduction
The integrins are a family of cell-surface glycoproteins which link the extracellular matrix (ECM) to the cytoskeleton (Hynes, 1992) . Each integrin is a heterodimer that contains an a and a b subunit with each subunit composed of a large extracellular domain, a single transmembrane region, and a short cytoplasmic domain (except b4). The speci®city of integrin interactions with ligands is determined by the combination of a particular a and b subunit. Integrin-mediated cell adhesion to the ECM plays important roles in a variety of biological processes including embryonic development, wound healing and cancer.
Studies have shown that integrins can mediate signal transduction across the plasma membrane (Aplin et al., 1998; Clark and Brugge, 1995; Schwartz et al., 1995) . Integrin-mediated cell adhesion has been shown to stimulate a variety of signaling cascades including activation of protein tyrosine kinases such as FAK and Src, protein serine/threonine kinases including protein kinase C, mitogen-activated protein kinases, and c-Jun N-terminal kinase, lipid kinases like PI-3-kinase, cytoplasmic alkalinization and calcium in¯ux. Interestingly, integrins also mediate inside-out signaling where integrin anity for extracellular ligands is regulated by a variety of signaling pathways triggerred by other cell surface receptors. Changes both in integrin conformation and/or clustering have been suggested to play a role in integrin anity regulation (Loftus and Liddington, 1997; Shattil et al., 1998) .
The cytoplasmic domains of integrins play a key role in both integrin signaling and anity regulation. Despite their relatively small size and lack of enzymatic activity, integrin b cytoplasmic domains are sucient to mediate integrin localization to focal contacts (LaFlamme et al., 1992; Marcantonio et al., 1990; Reszka et al., 1992) and induce FAK phosphorylation (Akiyama et al., 1994; Guan et al., 1991; Tahiliani et al., 1997) . They are also required for ®bronectin matrix assembly (Wu et al., 1995) and cell motility (Pasqualini and Hemier, 1994) . The cytoplasmic domains of both integrin a and b subunits have been implicated in the regulation of integrin anity (Hughes et al., 1996; O'Toole et al., 1994; .
The critical role of the cytoplasmic domains in integrin function implicates the importance of cytoplasmic proteins that modify or bind to integrin cytoplasmic domains. Consistent with integrin localization in focal contacts, several cytoskeletal proteins including talin, a-actinin, ®lamin and paxillin have been shown to interact with cytoplasmic domain of integrin b subunit, which may mediate integrincytoskeleton connections (Horwitz et al., 1986; Loo et al., 1998; Otey et al., 1990; Pfa et al., 1998; Sharma et al., 1995) . In addition, several intracellular signaling proteins have been reported to associate with integrin b cytoplasmic domains, which play interesting and important regulatory functions. These include cytohesion-1 (Kolanus et al., 1996) , FAK (Schaller et al., 1995) , ILK (Hannigan et al., 1996) , b3-endonexin (Shattil et al., 1995) , ICAP-1 (Chang et al., 1997; Zhang and Hemler, 1999) , and Rack1 (Liliental and Chang, 1998 ).
14-3-3 proteins are a highly conserved family of dimeric proteins ubiquitously expressed in all eukaryotic cells (for review, see Fu et al., 2000; Aitken et al., 1995) . Members of 14-3-3 family proteins have been shown to bind a number of signaling molecules by both phosphoserine motifs (Muslin et al., 1996; Yae et al., 1997) and non-phosphoserine mechanism (Clark et al., 1997; Masters et al., 1999; Wang et al., 1999) . Many of these 14-3-3-associated proteins are protooncogene and oncogene products. Association of 14-3-3 proteins with intracellular signaling molecules has been proposed to regulate their enzymatic activity, to bring dierent binding partners (e.g. enzyme and substrate) together, and to stabilize the conformation of the associated proteins. Expression of the 14-3-3 was increased signi®cantly in lung cancer tissues compared with the neighboring normal part of lung (Nakanishi et al., 1997) and in head and neck squamous carcinoma (Villaret et al., 2000) . 14-3-3g expression was increased in response to vessel damage and proliferative signals (Autieri et al., 1996) . These studies suggest that 14-3-3 proteins are involved in the regulation of mitogenic signaling as well as development of cancer.
To further understand integrin signaling and regulation, we employed the yeast two-hybrid screen to identify novel cellular proteins that bind to the integrin b1 cytoplasmic domain. We report here the association of 14-3-3b with integrin b1 cytoplasmic domain by a non-phosphoserine mechanism and the eect of 14-3-3b expression on integrin-mediated cell spreading and migration. These results suggest potential role of 14-3-3 proteins in the regulation of integrin functions.
Results
Identification of integrin b1 cytoplasmic domain interaction with 14-3-3b by yeast two hybrid screen
We employed yeast two-hybrid screen to identify protein(s) that can interact with the cytoplasmic domain of b1 integrin. A cDNA fragment encoding the complete b1 cytoplasmic domain was inserted into a modi®ed pAS2 vector (see Materials and methods) and used to screen a HeLa cell library (Hannon et al., 1993) . From approximately 2610 6 transformants, four clones (clones #10, #11, #20 and #21) were identi®ed that speci®cally interacted with the bait plasmid. Plasmid DNA from these clones was then isolated. Partial DNA sequencing indicated that clone #11 encodes almost a complete cDNA for 14-3-3b missing only the N-terminal 29 amino acids (residues 30 ± 247). Retransformation of clone #11 into yeast con®rmed its speci®c interaction with the bait plasmid containing the b1 cytoplasmic domain, but not the bait vector alone.
We then used a series of b1 cytoplasmic domain deletion and point mutations to map the potential binding site for clone #11 using yeast two hybrid system (Figure 1 ). Deletion of 13 amino acids from the b1 C-terminus of the integrin b1 cytoplasmic domain (D4) did not signi®cantly aect its interaction with clone #11. In contrast, removal of 28 amino acids (D3) or 42 residues (D1) prevented its binding to clone #11, suggesting that residues between the D3 and D4 mutants (776 ± 790) were involved in binding to 14-3-3b. 14-3-3 proteins are adaptor molecules that often bind to phosphorylated Ser motifs (Yae et al., 1997) . The Ser790 residue in the integrin b1 cytoplasmic domain has been reported to be phosphorylated in mitotic cell (Hynes, 1992) . However, mutation of Ser790 to Ala did not block the interaction, suggesting that Ser790 was not involved in b1 integrin binding to 14-3-3b. Likewise, mutation of Tyr788 to Phe did not aect its interaction with 14-3-3b, suggesting that Tyr788 in the NPXY motif is not necessary for the interaction. Clone #11 also interacted with the cytoplasmic domain of integrin b3 to a similar level as b3-endonexin (Shattil et al., 1995) . Together, these studies indicated that integrin b1 residues 776 ± 790 (other than Tyr788 or Ser790) that are also conserved in the integrin b3 cytoplasmic domain mediated its interaction with 14-3-3b in a phosphorylation independent manner.
Analysis of integrin b1 interaction with 14-3-3b in vitro and in mammalian cells
To determine whether the 14-3-3b fragment (clone #11, encoding residues 30 ± 247) could bind directly to the integrin b1 cytoplasmic domain in vitro, this fragment was inserted into the pGEX-2T vector to generate a GST fusion protein for binding assays. The cytoplasmic domain of b1 integrin was inserted into a mammalian expression vector pKH3 fused in frame with a triple HA epitope tag and a GCN4 dimerization segment. This plasmid was transfected into CHO cells and lysates were prepared and incubated with the GST fusion proteins that had been immobilized on glutathione-agarose beads. After washing, the bound Figure 1 Interaction of 14-3-3b with b1 integrin cytoplasmic domain and mutants in yeast two-hybrid system. Yeast strain HF7c was co-transformed with pGAD-#11 or pGAD-b3-endonexin and pAS2DD encoding integrin b1 cytoplasmic domain, its mutants, or integrin b3 cytoplasmic domain, as indicated. The growth of transformants on a synthetic medium lacking tryptophane, leucine and histidine are shown. The NPXY motifs are underlined and the S790 to A and Y788 to F mutations are shown in bold proteins were analysed by Western blotting with mAb 12CA5 for the HA epitope. Figure 2A shows that the integrin b1 cytoplasmic domain bound to the GST fusion protein containing the 14-3-3b fragment encoded by clone #11, but not GST alone. Although at a lower eciency, it also bound to the GST fusion protein containing an unknown protein fragment encoded by clone #10 that was isolated from the same yeast two-hybrid screen.
Association of 14-3-3b with endogenous integrin b1 in intact cells was also con®rmed using coimmunoprecipitations. Full-length 14-3-3b cDNA was derived from an EST clone using PCR and inserted into a mammalian expression vector pDHGST to generate pDHGST-14-3-3b encoding 14-3-3b fused to GST at the N-terminus (Han and Guan, 1999) , as described in Materials and methods. The fragment encoded by clone #10 was also inserted into the same vector to generate pDHGST-#10. 293T cells were transiently transfected with pDHGST-14-3-3b, pDHGST-#10, or pDHGST vector alone. The lysates were prepared and 14-3-3b was precipitated by incubation with glutathione-Sepharose beads. The bound proteins were resolved on SDS ± PAGE and subjected to Western blotting with anti-integrin b1 antibody. Figure 2B shows that integrin b1 was associated with 14-3-3b, but did not bind to the GST control. It was also associated with the fragment encoded by clone #10 although with less eciency. Together, these results con®rmed 14-3-3b interaction with integrin b1 through its cytoplasmic domain.
To further investigate interaction of 14-3-3b and integrin b1, we examined subcellular localization of these two proteins during cell adhesion. HFF cells were plated on FN or PLL for 30 or 120 min, and the distribution of endogenous 14-3-3b and integrin b1 was examined by co-immuno¯orescence staining ( Figure 3 ). We found that when cells were plated on FN, 14-3-3b and integrin b1 were partially co-localized at punctuate sites in the periphery of the cells resembling focal contacts at the earlier time point after plating. At the later stage after plating, integrin b1 is detected in focal contacts located both at the cell peripheral and the central cell bodies. In contrast, 14-3-3b was completely localized in the cytoplasm and absent from these focal contacts. Colocalization of 14-3-3b and integrin b1 was not detected in cells plated on PLL at either the early or late stage of cell adhesion. Together, these results showed that cell adhesion to FN stimulated a transient co-localization of 14-3-3b and integrin b1 in the early focal contacts structures in the cell periphery. They also suggested that interaction between 14-3-3b and integrin b1 is not constitutive, but temporally and spatially regulated.
Regulation of cell spreading and migration by 14-3-3b
To investigate the potential cellular functions of 14-3-3b association with integrin b1, we obtained inducible overexpression of 14-3-3b in NIH3T3 cells using the tetracycline regulated expression system as described in Materials and methods. Multiple clones were analysed for the expression of exogenous 14-3-3b by Western blotting using 12CA5, a monoclonal antibody against the HA epitope tag fused to the N-terminus of exogenous 14-3-3b. Figure 4A shows expression of the exogenous 14-3-3b in several clones upon induction by removal of tetracycline in the media (compare lanes I with lanes U). Western blotting with anti-14-3-3 antibody con®rmed expression of the exogenous 14-3-3b (arrow) which is slightly larger than the endogenous 14-3-3s (arrowheads, the lower band is 14-3-3b) due to the fusion of three HA epitopes at the N-terminus ( Figure 4B ). The clone with the highest expression (#2) was designated as 14-3-3 cells and was used for further analysis.
The eect of induced overexpression of 14-3-3b on cell adhesion on FN was examined by cell spreading assays ( Figure 5 ). At 5 min after attachment, little cell spreading was observed under uninduced or induced conditions for either 14-3-3 cells or the Mock cells, although a small fraction of 14-3-3 cells under induced condition appeared to start spreading (Figure 5A ± D). At 10 min after attachment, a signi®cantly higher fraction of 14-3-3 cells under induced condition was spread compared with the cells under uninduced conditions (compare Figure 5G ,H). The Mock cells showed similar spreading under both induced and uninduced conditions, which is comparable with the 14-3-3 cells under the uninduced conditions ( Figure  5E ± G). At 20 min after attachment, smaller but signi®cant increased fraction of cell spreading was also Figure 2 In vitro and in vivo interaction between 14-3-3b and b1 integrin. (A). Immobilized GST-#11, GST-#10 or GST was incubated with lysates from CHO cells that had been transfected with pKH3DD-b1cyto. After washing, the bound proteins were analysed by Western blotting with 12CA5. An aliquot of the lysate was also analysed directly (input). (B). 293T cells were transfected with pDHGST-14-3-3b, pDHGST-#10, or pDHGST vector, as indicated. Two days after transfection, 14-3-3b was pulled-down from the lysates using glutathione-coupled agarose beads. They were then analysed by Western blotting with antiintegrin b1 antibody. An aliquot of the lysates was also analysed directly (WCL). Molecular weight markers are shown on the left and the position of integrin b1 is marked by an arrow on the right observed for 14-3-3 cells under induced conditions compared with that under the uninduced conditions or Mock cells under both conditions ( Figure 5I ± L) . Quantitation of the results from three independent experiments indicated similar rate of cell spreading for the Mock cells under induced and uninduced conditions ( Figure 5M ). In contrast, induction of the exogenous 14-3-3b expression resulted in an approximately 2.5-fold and 1.5-fold increases in cell spreading at 10 and 20 min after cell attachment, respectively (panels N). Similar results were obtained from analysis of another independent clone with inducible 14-3-3b expression ( Figure 5O ). At later time points and in growing cells, both 14-3-3 and Mock cells under either Figure 3 Subcellular localization of integrin b1 and 14-3-3b in HFF cells. HFF cells were plated on ®bronectin-(FN) or PLLcoated coverslips for 30 or 120 min as indicated. They were then ®xed, permeabilized, and double stained with the monoclonal antiintegrin b1 antibody (left panels) and the polyclonal anti-14-3-3b antibody (middle panels). The merged images are shown on the right panels Oncogene Integrin b1 interaction with 14-3-3b DC Han et al conditions showed complete spreading without any apparent dierences (data not shown). Lastly, induction of 14-3-3b expression did not increase cell spreading on PLL (Figure 6 ), suggesting a speci®c eect of 14-3-3b on integrin-mediated cell adhesion. Together, these results suggest that 14-3-3b may regulate the rate of cell spreading at the early stage of integrin-mediated cell adhesion.
We also evaluated potential eects of 14-3-3b on cell migration on FN or PLL using a wound closure assay. As shown in Figure 7A , when plated on FN, induced overexpression of 14-3-3b accelerated the closure of the wound in comparison to cells under uninduced conditions. Quantitation of the results indicated that induction of the exogenous 14-3-3b expression resulted in an approximately 50% increases in cell migration ( Figure 7C ). In contrast, 14-3-3b did not increase cell migration on PLL, but rather inhibited it slightly ( Figure 7B,C) . To exclude the potential contribution of increased cell proliferation in stimulation of wound closure, we also assayed for growth of 14-3-3 cells under the induced and uninduced conditions. Figure  7D showed a slightly reduced rate of proliferation for 14-3-3 cells under the induced conditions in comparison to that under the uninduced conditions. Together these results suggest that the increased wound closure on FN upon 14-3-3b expression was indeed due to an increased cell migration and not by altered cell proliferation rate.
Effects of 14-3-3b on the tyrosine phosphorylation of FAK and its substrates Focal adhesion proteins, p130cas, paxillin and FAK, have been implicated in a role of integrin-mediated cell spreading and migration (Cary et al., 1996 (Cary et al., , 1998 Gilmore and Romer, 1996; Ilic et al., 1995; Klemke et al., 1998; Richardson and Parsons, 1996) . Furthermore, p130cas has been shown to bind 14-3-3z in an adhesion-dependent manner (Garcia-Guzman et al., 1999) . To investigate whether 14-3-3b may regulate cell spreading and migration through these proteins, we examined their tyrosine phosphorylation upon induction of exogenous 14-3-3b expression. 14-3-3 cells under either uninduced or induced conditions were removed from the plates and replated on FN (lanes FN) or kept in suspension (lanes Sus). Western blotting of the total cell lysates with anti-14-3-3b con®rmed the induced expression of 14-3-3b in both suspended and adherent cells ( Figure 8A ). As expected, cell adhesion induced tyrosine phosphorylation of several proteins, most prominently bands in the range of 120 and at 70 kDa ( Figure 8B ). However, the increased phosphorylation was similar in cells under induced and uninduced conditions, suggesting that the induced overexpression of 14-3-3b did not regulate tyrosine phosphorylation of these proteins.
To analyse tyrosine phosphorylation of FAK, the cell lysates were immunoprecipitated with anti-FAK followed by Western blotting with anti-phosphotyrosine antibody PY-20. As shown in Figure 9A overexpression of exogenous 14-3-3b did not aect FAK phosphorylation compared with uninduced cells, although FAK phosphorylation was enhanced upon replating on FN as expected. Western blotting of the immunoprecipitates with anti-FAK con®rmed the presence of similar amounts of FAK (right panel). Similar analysis indicated that inducible overexpression of 14-3-3b did not aect cell adhesion stimulated tyrosine phosphorylation of p130cas ( Figure 9B ) or paxillin ( Figure 9C ). Taken together, these results demonstrate that regulation of integrin-dependent cell adhesion and migration by 14-3-3b is not through its eects on FAK or its substrates, p130cas and paxillin.
Discussion
The 14-3-3 family of proteins are highly conserved proteins ubiquitously expressed in all eukaryotic cells (Aitken et al., 1995) . Members of the 14-3-3 family proteins have been shown to interact with many key signaling molecules to regulate intracellular signaling events in cell proliferation, dierentiation and apoptosis (Bonnefoy-Berard et al., 1995; Craparo et al., 1997; Fu et al., 1994; Garcia-Guzman et al., 1999; Hausser et al., 1999; Liu et al., 1997; Meller et al., 1996; Reuther et al., 1994; Zhang et al., 1997 . In this paper, we have identi®ed a novel interaction between 14-3-3b and b1 integrin through its cytoplasmic domain. This interaction was identi®ed initially using the yeast two hybrid screening and was subsequently con®rmed by in vitro binding assays and co-immunoprecipitation in intact cells. Interestingly, immuno¯uorescence staining of endogenous integrin b1 and 14-3-3b suggested that this interaction was temporally and spatially regulated by cell adhesion. Together with the recent ®nding of Figure 4 Inducible expression of 14-3-3b in NIH3T3 clones. Lysates were prepared from several NIH3T3 cell clones with inducible 14-3-3b expression under uninduced (lanes U) and induced (lanes I) conditions. They were analysed by Western blotting with 12CA5 (A) or anti-14-3-3 antibody that recognizes all endogenous 14-3-3 isoforms (B). The arrows on the right indicate exogenous 14-3-3b. The arrowheads indicate endogenous 14-3-3e (upper) and other 14-3-3s including 14-3-3b. Molecular weight markers are shown on the left 14-3-3z interaction with p130cas (Garcia-Guzman et al., 1999), these results suggested a potentially novel cellular function for 14-3-3 proteins in the regulation of integrin-mediated cell adhesion and signaling events.
14-3-3 proteins have been shown to bind speci®c phosphoserine-containing motifs, RSXpSXP and RXY/FXpSXP present in many of its binding partners (Aitken et al., 1995; Muslin et al., 1996; Yae et al., 1997) . Although it was reported to be phosphorylated under some conditions (Hynes, 1992) , the single serine residue in the cytoplasmic domain of integrin b1 is not present in these motifs. Indeed, mutation of this serine to alanine did not block 14-3-3b interaction with the integrin b1 cytoplasmic domain (Figure 1 ). Therefore, integrin interaction with 14-3-3b is likely to be mediated through non-phosphoserine motifs as in several other cases of protein interactions with 14-3-3 proteins described recently (Clark et al., 1997; Masters et al., 1999; Wang et al., 1999) .
Analysis of truncation and other point mutation also excluded a role for the Tyr residues in either of the two NPXY motifs in mediating integrin binding to 14-3-3b (Figure 1) . These analyses revealed a potential role for residues 776 ± 790 in the middle region of integrin b1 cytoplasmic domain for binding 14-3-3b. Interestingly, we also found that the cytoplasmic domain of integrin b3 could also bind to 14-3-3b using the yeast two-hybrid assays (Figure 1) . These results suggested that the conserved residues between integrins b1 and b3 within this region are critical in mediating the binding to 14-3-3b. Future experiments will be necessary to delineate the critical residues on both integrin cytoplasmic domains and 14-3-3 proteins involved in this non-phosphoserine dependent interaction.
The cellular functions of the 14-3-3b interaction with integrin b1 are not completely clear at present. In support of a potential role of 14-3-3 proteins in the regulation of integrin functions, we found that inducible expression of exogenous 14-3-3b increased cell spreading and migration on FN using a tetracycline regulated expression system. Expression of 14- 3-3b did not aect cell spreading or migration on nonintegrin substrate PLL, providing further support for a functional signi®cance of 14-3-3b interaction with integrins. There are several possible models to explain the regulation of integrin-mediated cell adhesion and migration by 14-3-3b. First, 14-3-3 proteins have been shown to bind a variety of other cellular proteins. Formation of homodimers and hetrodimers of 14-3-3 proteins have been shown to be important for their biological activities. It is therefore possible that each subunit of the 14-3-3 dimer can bind to a dierent cellular protein and dimerization will bring these components in one place to coordinate multiple reactions. For example, Cdc25 and Bcr have been shown to interact with Raf-1 in a 14-3-3 dependent manner (Braselmann and McCormick, 1995; Conklin et al., 1995) . This raises the interesting possibility that 14-3-3b may mediate an indirect interaction of integrin cytoplasmic domain with signaling molecules such as PI-3K, PKC or Raf to trigger downstream pathways in cell adhesion and migration. Indeed, some of these signaling molecules have been found to co-aggregate with integrins upon binding of beads coated with ligand or anti-integrin antibodies (Miyamoto et al., 1995) . In addition, integrin activation has been shown to stimulate activities of PI-3K (Chen and Guan, 1994; Khwaja et al., 1997) , PKC (Chun and Jacobson, 1993; Miranti et al., 1999; Vuori and Ruoslahti, 1993) and Raf (Lin et al., 1997) .
Alternatively, binding of 14-3-3b to integrins may alter integrin anity for ligands by an inside-out signaling mechanism, which may enhance the integrin's ability to mediate cell spreading and migration. Conformational changes and/or integrin clustering have been suggested to be responsible for regulation of integrin anity by intracellular signaling (Loftus and Liddington, 1997; Shattil et al., 1998) . The possibility that binding of the dimeric 14-3-3b to the integrin b1 cytoplasmic domain may induce dimerization (or clustering) of integrins is particularly interesting, which will require further investigation. It is also important to note that these two possible mechanisms (inducing integrin clustering and recruiting signaling molecules to integrin as discussed above) are not mutually exclusive.
Lastly, we can not exclude completely the possibility that 14-3-3b regulated cell spreading and migration by some indirect mechanisms independent of its direct association with integrin b1 as identi®ed here. For example, binding of 14-3-3b with signaling molecules such as PI-3K (Bonnefoy-Berard et al., 1995) , PKC (Morgan and Burgoyne, 1992; Toker et al., 1992) , and Raf (Fantl et al., 1994; Freed et al., 1994; Fu et al., 1994; Irie et al., 1994) might alter their activities and/or subcellular localizations. Signaling pathways from these molecules could then modulate integrin anity resulting in increased cell spreading and migration. Development of speci®c inhibitors for integrin b1/14-3- 3b interaction and/or use of speci®c 14-3-3b mutants lacking interactions with integrin b1 only (but retain its binding to other signaling molecules) will be necessary to con®rm that regulation of integrin-mediated cell spreading and migration by 14-3-3b is due to its speci®c interaction with integrin b1, but not other indirect mechanisms.
Tyrosine phosphorylation of FAK and its substrates p130cas and paxillin is an early event of integrinmediated cell adhesion, which has been shown to play a role in cell spreading and migration (Cary et al., 1996 (Cary et al., , 1998 Gilmore and Romer, 1996; Ilic et al., 1995; Klemke et al., 1998; Richardson and Parsons, 1996) . However, inducible overexpression of exogenous 14-3-3b did not aect phosphorylation of these molecules compared with uninduced cells under either suspended or attached conditions (Figure 8 ). Furthermore, we did not observe any dierences in the overall pattern of tyrosine phosphorylation of cellular proteins ( Figure  7) . These results suggested that 14-3-3b overexpression Figure 7 Eect of inducible expression of 14-3-3b on cell migration and proliferation. Uninduced (U) or induced (I) 14-3-3 cells were plated on FN-coated dishes (A) or PLL-coated dishes (B). Four hours later, a wound was made by scraping cell monolayer with a pipet tip (0 h). The cells were then washed, incubated for 18 h to allow migration into the wounded area (18 h). (C) Quantitation of cell migration by counting the number of cells that had migrated into the cell-free space. Four dierent areas were randomly chosen from one plate and more than 200 cells were counted from each wounded area. Data was normalized to the number of cells migrated under uninduced condition. (D) Cells were incubated in the growth media under uninduced (open square) or induced (closed circle) conditions. They were counted at 1-day intervals as described in Material and methods. Average and standard deviations from three independent experiments are shown Oncogene Integrin b1 interaction with 14-3-3b DC Han et al stimulated integrin-mediated cell spreading and migration by a mechanism independent of FAK signaling pathways.
In summary, we have identi®ed a novel interaction between integrin b1 cytoplasmic domain and 14-3-3b and also provided evidence for a potential role of 14-3-3b in the regulation of integrin-mediated cell adhesion and migration. Future studies will be directed at understanding the mechanisms by which 14-3-3b and its interactions with integrins aect these and potentially other cellular functions.
Materials and methods

Materials
Protein A-Sepharose 4B, glutathione-agarose beads, soybean trypsine inhibitor, poly-L-lysine (PLL), and human plasma ®bronectin (FN) were purchased from Sigma. G418 and LipofectAMINE were purchased from Life Technologies, Inc. Mouse mAb 12CA5, rabbit polyclonal anti-FAK serum and rabbit polyclonal anti-integrin b1 (Marcantonio and Hynes, 1988) have been described previously. The following antibodies were purchased as indicated: mouse mAb anti-integrin b1, P4C10, from Life Technologies, Inc.; mouse mAb antiphosphotyrosine PY-20, mouse mAb anti-FAK and mouse mAb anti-paxillin from Transduction Laboratories (Lexington, KY, USA); and rabbit polyclonal anti-p130 cas , rabbit polyclonal anti-14-3-3 (K-19) and rabbit polyclonal anti-14-3-3b (C-20) from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Yeast two-hybrid screen
A DNA fragment containing dimerization domain of GCN4 was obtained by PCR using sense (5'-CGCGGATCCAAA-GAATGAAACTTGAAGAC) and antisense (5'-CGCGTC-GACTTCGCCAACTAATTTCTTTAATC) oligonucleotides with pLEX-GCN4 (kind gift of Dr K Struhl) as a template. PCR product was digested with BamHI and SalI, gel puri®ed, and then inserted into the corresponding site of pAS2 (Clontech, CA, USA) to generate a modi®ed bait vector pAS2DD. The cytoplasmic domain of integrin b1 containing residues 748 ± 803 was synthesized by PCR using sense (5'-CGCGTCGACATTGGACTTGCATTGTTATT-GAT) and antisense (5'-GTAAAATCACTGCAGTTTGCC) oligonucleotides with chicken integrin b1 (Solowska et al., 1989) as a template. The PCR product was digested with SalI and PstI, gel puri®ed, and then inserted into the corresponding site of pAS2DD to generate plasmid pAS2DD-b1cyto. The bait vectors encoding deletion mutants D1, D3, and D4 and point mutant Y788F were prepared in a similar manner using the corresponding mutant integrin b1 (Marcantonio et al., 1990; Reszka et al., 1992) as templates in PCR. Overlap extension method was employed to create the S790A mutant using the sense (5'-ACAAGGCCG-CAGTGACAA) and antisense (5'-AGTTGTCACTGCGG-CCTTGTAAA) oligonucleotides, as described previously (Cary et al., 1996) . The bait vector encoding integrin b3 containing residues 733 ± 789 was synthesized by PCR using sense (5'-GGGAGCGATCGTCGACATTGGCCTTGC) and antisense (5'-AGGAAGAATCCCTGCAGGAGGCATT) nucleotides with human integrin b3 as a template. pGADb3-endonexin was generous gift from Dr Shattil (Shattil et al., 1995) .
The HF7c yeast strain was ®rst transformed with pAS2DD-b1cyto. Expression of the bait protein containing integrin b1 cytoplasmic domain was con®rmed by Western blotting of yeast cell lysates with anti-integrin b1 (data not shown). They were transformed subsequently with a HeLa cell cDNA library fused to the GAL4 transcriptional activation domain ( (Hannon et al., 1993) ; generous gift of Dr G Hannon). Transformants were plated on agar selection medium lacking tryptophan (Trp 
His
7 plates (Hannon et al., 1993) . Plasmid DNA was puri®ed from the His + b-Gal + colonies. They were then retransformed into yeast with dierent bait vectors to determine speci®city and the inserts were sequenced using Sequenase 2.0.
Construction of cDNA expression vectors
The 14-3-3b cDNA lacking amino terminal 29 residues (#11) or the unknown cDNA insert (#10) was excised from the prey plasmid pGAD-#11 or pGAD-#10 and cloned into pGEX-KG to generate pGEX-#11 or pGEX-#10, respectively. cDNA encoding the integrin b1 cytoplasmic domain together with the GCN4 dimerization domain was excised from the bait plasmid pAS2DD-b1cyto and inserted into mammalian expression vector pKH3 to generate pKH3DD-b1cyto. Full length 14-3-3b was obtained by PCR using the sense (5'-CGCGGATCCATGACAATGGATAAAAGT-GAGC) and antisense (5'-CCGAATTCGAGGGTACA-GAGTGACACTGG) oligonucleotides with an EST clone containing 14-3-3b (EST590806, ATCC) as a template. The PCR product was digested with BamHI and EcoRI, and then inserted into mammalian expression vector pDHGST (Han and Guan, 1999) at corresponding site to generate pDHGST-14-3-3b. It was also inserted into pKH3 to produce pKH3-14-3-3b. 14-3-3b cDNA fused to the triple hemagglutinin (HA) epitope tag was then excised from pKH3-14-3-3b by digest with SalI and ClaI, and inserted into the corresponding site in pTet-Splice (Life Technologies, Inc) to creatr pTetSplice-14-3-3b.
Cell culture and transfections
293T cells and HFF cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Life Technologies, Inc). CHO cells were maintained in F12 medium plus 10% FBS. Transient transfections of 293T and CHO cells were performed using Lipofectamine (Life Technologies, Inc) according to the manufacturer's guidelines.
NIH3T3 cells were maintained in DMEM with 10% calf serum (CS, Life Technologies, Inc.). pTet-Splice-14-3-3b was transfected into NIH3T3 cells along with the plasmids pTettTAK (Life Technologies, Inc.) and pSV2neo using LipofectAMINE (Life Technologies, Inc.), as described previously (Han and Guan, 1999; Zhao et al., 1998) . G418-resistant clones with inducible expression of 14-3-3b were then identi®ed by Western blotting with 12CA5 of cell lysates prepared under uninduced and induced conditions, as described previously (Zhao et al., 1998) . Mock cells were generated in a similar manner with pTet-Splice vector without insert. The selected cell clones were maintained in DMEM with 10% CS, 0.5 mg/ml G418 and 0.5 mg/ml of tetracycline to suppress exogenous 14-3-3b expression until experiments as indicated.
Preparation of GST fusion proteins and in vitro binding assays
GST fusion proteins were produced and puri®ed as described previously (Xing et al., 1994) . GST fusion proteins (5 mg) were immobilized on glutathione-agarose beads and then incubated for 90 min at 48C with lysates (200 mg) prepared from CHO cells that had been transfected with pKH3DD-b1 cyto. After washing, the bound proteins were analysed by Western blotting with 12CA5 (1 : 1000 dilution) as described below.
Immunoprecipitation and Western blotting
For most experiments, subcon¯uent cells were washed twice with ice-cold PBS and then lysed with 1% NP-40 lysis buer, as described previously (Han and Guan, 1999) . For some experiments, cell lysates were prepared from suspended cells, or cells that had been re-plated on FN using ice-cold modi®ed RIPA buer (50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecylsulfate, 5 mM EDTA, 30 mM Na 2 HPO 4 , 50 mM NaF, 1 mM NaVO 4 , 1 mM PMSF, 10 mg/ml aprotinin and 20 mg/ ml leupeptin), as described previously (Han and Guan, 1999) . Lysates were cleared by centrifugation and total protein concentration was determined using Bio-Rad Protein Assay (Hercules, CA, USA). For`pull-down' assays using GSTfusion proteins, 30 ± 50 ml of glutathione-coupled beads were added to lysates and rotated for 30 min at 48C. After washing ®ve times with lysis buer, the samples were resolved using SDS ± PAGE, and transferred to nitrocellulose membrane (Schleicher and Schuell, Inc., NH, USA). Immunoprecipitations were carried out by incubating cell lysates with appropriate antibodies as indicated for 2 h at 48C, followed by incubation for 1.5 h with protein A-Sepharose. After washing, immune complexes were resolved using SDS ± PAGE. Western blotting was carried out using horseradish peroxidase-conjugated IgG as a secondary antibody and the Amersham ECL system for detection.
Immunofluorescence staining
Cells were processed for immuno¯uorescence staining as described with minor modi®cation (Guan et al., 1991) . Human foreskin ®broblasts (HFF) cells were plated on 18 mm coverslip that was coated with 10 mg/ml human plasma FN or 50 mg/ml of PLL. Cells were incubated in a 378C incubator to allow cells to attach and spread. At the end of incubation, the cells were ®xed with 3% formaldehyde for 15 min, washed three times, permearized with 0.5% Triton X-100, washed three times, and stained with primary antibodies (a-integrin b1, P4C10, (1 : 100), a-14-3-3b (1 : 200)) in the presence of 10% goat serum for 1 h at room temperature. After washing three times, the bound rabbit IgG and mouse IgG were detected with FITC-conjugated anti-rabbit (1 : 300) and rhodamine-conjugated anti-mouse (1 : 150) antibodies, respectively. Image of stained cells was captured using an immuno¯uorescence microscope.
Cell spreading assays
Prior to experiments, cells were incubated for 2 days in medium with (uninduced) or without (induced) 0.5 mg/ml tetracycline. They were collected by trypsinization, washed once with medium containing 0.5 mg/ml of soybean trypsin inhibitor and washed two more times with medium only. Then, cells were maintained in suspension for 1 h and replated on dishes that had been coated with 10 mg/ml FN or 50 mg/ml PLL and blocked by 2 mg/ml BSA. Cells were allowed to spread for the indicated times at 378C and then photographed. Spread cells were de®ned as cells with irregular morphology and lacking phase-brightness and nonspread cells were rounded and phase-bright under microscope.
Cell migration assays
Uninduced or induced cells (1610 6 ) were plated on FN (10 mg/ml) or PLL (50 mg/ml) coated plates (60 mm) in complete growth media in the presence or absence of tetracycline (0.5 mg/ml). After 4 h, wounds were made by manual scraping of the cell monolayer with a pipet tip. The dishes were washed, replenished with media in the presence or absence of tetracycline (0.5 mg/ml), and photographed under phase contrast microscope (6100). They were then placed in the tissue culture incubator, and the matched wound regions were photographed again 18 h later.
Cell growth measurement
Uninduced or induced cells (2610 5 ) were plated on 60 mm dishes in growth media with or without tetracycline (0.5 mg/ ml). Each day after initial plating, cells were trypsinized from three dierent dishes and counted for cell numbers under either uninduced or induced conditions.
Abbreviations
The abbreviations used are: ECM, extracellular matrix; PLL, poly-L-lysine; FN, human plasma ®bronectin; DMEM, Dulbecco's modi®ed Eagle's medium; FBS, fetal bovine serum; CS, calf serum.
